Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.93 -0.03 (-0.51%)
As of 06/4/2025 03:45 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.34 billion
P/E Ratio
35.18
Consensus Rating
Strong Buy
Volume
15,822 shares
Average Volume
85,236 shares
Today's Range
$4.89
$4.97
Bitcoin Depot stock logo

2. Bitcoin Depot NASDAQ:BTM

$4.49 -0.11 (-2.39%)
As of 06/4/2025 04:00 PM Eastern

Bitcoin Depot Inc owns and operates a network of cryptocurrency kiosks in North America. Its customers can buy and sell bitcoin, litecoin, and ethereum cryptocurrencies using the BTM kiosk network and other services. More about Bitcoin Depot

Market Capitalization
$288.76 million
P/E Ratio
-4.83
Consensus Rating
Buy
Consensus Price Target
$4.83 (+7.6% Upside)
Volume
1.42 million shares
Average Volume
596,565 shares
zSpace stock logo

3. zSpace NASDAQ:ZSPC

$4.84 +0.48 (+11.01%)
As of 06/4/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$110.75 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+209.9% Upside)
Volume
43,703 shares
Average Volume
66,217 shares
Today's Range
$4.15
$4.92
OS Therapies stock logo

4. OS Therapies NYSE:OSTX

$1.66 +0.07 (+4.40%)
As of 06/4/2025 04:00 PM Eastern

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$46.64 million
P/E Ratio
-1.93
Consensus Rating
Buy
Consensus Price Target
$18.00 (+984.3% Upside)
Volume
245,721 shares
Average Volume
463,968 shares
Cardiol Therapeutics stock logo

5. Cardiol Therapeutics NASDAQ:CRDL

$1.45 +0.14 (+10.69%)
As of 06/4/2025 04:00 PM Eastern

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$108.22 million
P/E Ratio
-3.72
Consensus Rating
Buy
Consensus Price Target
$8.67 (+497.7% Upside)
Volume
506,742 shares
Average Volume
355,774 shares
Denison Mines stock logo

6. Denison Mines NYSEAMERICAN:DNN

$1.65 -0.04 (-2.37%)
As of 06/4/2025 04:10 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.48 billion
P/E Ratio
-165.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+81.8% Upside)
Volume
141.70 million shares
Average Volume
37.77 million shares
Bioceres Crop Solutions stock logo

7. Bioceres Crop Solutions NASDAQ:BIOX

$4.92 -0.08 (-1.60%)
As of 06/4/2025 04:00 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$308.54 million
P/E Ratio
246.12
Consensus Rating
Buy
Consensus Price Target
$8.63 (+75.3% Upside)
Volume
75,551 shares
Average Volume
174,487 shares
OnKure Therapeutics stock logo

8. OnKure Therapeutics NASDAQ:OKUR

$2.89 +0.20 (+7.43%)
As of 06/4/2025 04:00 PM Eastern

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$39.04 million
P/E Ratio
-0.24
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,018.8% Upside)
Volume
158,894 shares
Average Volume
111,992 shares
GeoVax Labs stock logo

9. GeoVax Labs NASDAQ:GOVX

$1.12 +0.07 (+6.67%)
As of 06/4/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$17.02 million
P/E Ratio
-0.31
Consensus Rating
Buy
Consensus Price Target
$11.10 (+891.1% Upside)
Volume
291,794 shares
Average Volume
514,993 shares
Quince Therapeutics stock logo

10. Quince Therapeutics NASDAQ:QNCX

$1.09 +0.04 (+3.81%)
As of 06/4/2025 04:00 PM Eastern

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$49.56 million
P/E Ratio
-0.88
Consensus Rating
Buy
Consensus Price Target
$8.00 (+633.9% Upside)
Volume
85,493 shares
Average Volume
287,195 shares
Reviva Pharmaceuticals stock logo

11. Reviva Pharmaceuticals NASDAQ:RVPH

$0.81 0.00 (-0.13%)
As of 06/4/2025 04:00 PM Eastern

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$38.12 million
P/E Ratio
-0.73
Consensus Rating
Buy
Consensus Price Target
$9.00 (+1,005.0% Upside)
Volume
392,352 shares
Average Volume
1.14 million shares
Immunic stock logo

12. Immunic NASDAQ:IMUX

$0.78 +0.04 (+6.11%)
As of 06/4/2025 04:00 PM Eastern

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$74.26 million
P/E Ratio
-0.63
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,396.8% Upside)
Volume
1.11 million shares
Average Volume
790,325 shares
Mereo BioPharma Group stock logo

13. Mereo BioPharma Group NASDAQ:MREO

$2.55 -0.10 (-3.77%)
As of 06/4/2025 04:00 PM Eastern

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$405.45 million
P/E Ratio
-36.43
Consensus Rating
Buy
Consensus Price Target
$7.71 (+202.5% Upside)
Volume
2.89 million shares
Average Volume
1.12 million shares
Rezolve AI stock logo

14. Rezolve AI NASDAQ:RZLV

$2.05 +0.10 (+5.13%)
As of 06/4/2025 04:00 PM Eastern

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$426.94 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+192.7% Upside)
Volume
2.84 million shares
Average Volume
5.08 million shares
Today's Range
$1.95
$2.09
MannKind stock logo

15. MannKind NASDAQ:MNKD

$4.35 -0.07 (-1.58%)
As of 06/4/2025 04:00 PM Eastern

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.32 billion
P/E Ratio
62.14
Consensus Rating
Buy
Consensus Price Target
$10.00 (+129.9% Upside)
Volume
2.24 million shares
Average Volume
2.37 million shares
Full House Resorts stock logo

16. Full House Resorts NASDAQ:FLL

$3.14 -0.04 (-1.26%)
As of 06/4/2025 04:00 PM Eastern

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$112.97 million
P/E Ratio
-2.66
Consensus Rating
Buy
Consensus Price Target
$5.67 (+80.5% Upside)
Volume
148,125 shares
Average Volume
143,013 shares
Solid Biosciences stock logo

17. Solid Biosciences NASDAQ:SLDB

$3.84 +0.34 (+9.71%)
As of 06/4/2025 04:00 PM Eastern

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$297.66 million
P/E Ratio
-1.26
Consensus Rating
Buy
Consensus Price Target
$14.90 (+288.0% Upside)
Volume
1.84 million shares
Average Volume
1.10 million shares
Alumis stock logo

18. Alumis NASDAQ:ALMS

$3.41 -0.04 (-1.16%)
As of 06/4/2025 04:00 PM Eastern

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$161.02 million
Consensus Rating
Buy
Consensus Price Target
$24.86 (+628.9% Upside)
Volume
554,024 shares
Average Volume
389,272 shares
Today's Range
$3.39
$3.77
Akebia Therapeutics stock logo

19. Akebia Therapeutics NASDAQ:AKBA

$3.64 +0.22 (+6.43%)
As of 06/4/2025 04:00 PM Eastern

Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. More about Akebia Therapeutics

Market Capitalization
$956.00 million
P/E Ratio
-15.83
Consensus Rating
Buy
Consensus Price Target
$6.75 (+85.4% Upside)
Volume
12.18 million shares
Average Volume
3.02 million shares
Electrovaya stock logo

20. Electrovaya NASDAQ:ELVA

$3.25 -0.09 (-2.69%)
As of 06/4/2025 04:00 PM Eastern

Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about Electrovaya

Market Capitalization
$130.35 million
P/E Ratio
-81.25
Consensus Rating
Buy
Consensus Price Target
$6.10 (+87.7% Upside)
Volume
57,089 shares
Average Volume
55,698 shares
Orchestra BioMed stock logo

21. Orchestra BioMed NASDAQ:OBIO

$3.26 +0.02 (+0.62%)
As of 06/4/2025 04:00 PM Eastern

Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMed

Market Capitalization
$124.13 million
P/E Ratio
-2.02
Consensus Rating
Buy
Consensus Price Target
$14.20 (+335.6% Upside)
Volume
424,455 shares
Average Volume
166,532 shares
Contineum Therapeutics stock logo

22. Contineum Therapeutics NASDAQ:CTNM

$4.41 -0.33 (-6.96%)
As of 06/4/2025 04:00 PM Eastern

Contineum Therapeutics, Inc, a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. More about Contineum Therapeutics

Market Capitalization
$114.10 million
P/E Ratio
-2.24
Consensus Rating
Buy
Consensus Price Target
$22.50 (+410.2% Upside)
Volume
87,052 shares
Average Volume
85,486 shares
Western Copper & Gold stock logo

23. Western Copper & Gold NYSE:WRN

$1.26 +0.05 (+4.13%)
As of 06/4/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$252 million
P/E Ratio
-63.00
Consensus Rating
Buy
Consensus Price Target
$4.25 (+237.3% Upside)
Volume
314,899 shares
Average Volume
372,044 shares
Ur-Energy stock logo

24. Ur-Energy NYSEAMERICAN:URG

$0.83 +0.02 (+2.62%)
As of 06/4/2025 04:10 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur-Energy

Market Capitalization
$302.20 million
P/E Ratio
-6.38
Consensus Rating
Buy
Consensus Price Target
$2.30 (+177.1% Upside)
Volume
4.20 million shares
Average Volume
4.26 million shares
United States Antimony stock logo

25. United States Antimony NYSE:UAMY

$2.75 +0.09 (+3.38%)
As of 06/4/2025 04:00 PM Eastern

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$324.29 million
P/E Ratio
-68.75
Consensus Rating
Buy
Consensus Price Target
$3.38 (+22.7% Upside)
Volume
3.72 million shares
Average Volume
2.31 million shares